Close

BPAX Financial Facts

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in shares): 11.47M
DILUTED NET LOSS PER SHARE (in dollars per share): 0.22
See Full Income Statement

TOTAL ASSETS: 319.38M
Accounts payable: 4.73M
See Full Balance Sheet

BioSante Pharmaceuticals, Inc. (BPAX) Earnings

  |   Expand Research on BPAX
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -15.9% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +0.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/8/12 Q312 -$0.27-$0.36 +$0.09N/A$100K N/A Details
11/9/11 Q311 -$0.12-$0.14 +$0.02$182.78K$30K N/A Details
7/25/11 Q211 -$0.16-$0.10 -$0.06N/AN/A N/A Details
5/10/11 Q111 -$0.20-$0.14 -$0.06N/A$10K N/A Details